For press requests, please contact Jimmy Wyderko at jwyderko@economicliberties.us or 301-221-7778.


Economic Liberties Applauds Whitaker Confirmation at FAA

October 24, 2023 — In response to news that the United States Senate has voted to confirm Michael G. Whitaker to be Administrator of the Federal Aviation Administration (FAA), the American Economic Liberties Project released the following statement.

New Economic Liberties Toolkit Lays Out How State Lawmakers Can Rein in Big Medicine

October 23, 2023 — As corporate consolidation in healthcare produces unprecedented drug shortages, rising prices, and unacceptable working conditions, all while giant healthcare companies rake in massive profits, the American Economic Liberties Project today released a new policy toolkit “Tools to Challenge Big Medicine: A Guide for State Lawmakers.” It outlines practical steps that state lawmakers can take to reform the American healthcare industry and challenge corporate power.

CFPB’s New Personal Financial Data Rights Rulemaking is a Win for Consumers and Competition

October 20, 2023 — In response to a new proposed rule from the Consumer Financial Protection Bureau (CFPB) to facilitate enhanced consumer access to their financial data and promote competition — through a provision of the Dodd-Frank Act known as Section 1033 — the American Economic Liberties Project released the following statement. 

It’s Time for the Federal Judiciary to Enter the 21st Century and Create a Transparent Federal Court System

October 19, 2023 — In response to news that Judge Amit Mehta has denied a motion filed by the New York Times and other prominent media outlets’ for increased access to the U.S. v. Google trial — the most important antitrust trial of the century — the American Economic Liberties Project released the following statement. 

Congress Can Address Generic Drug Shortages By Reining in Consolidated GPOs, New Policy Brief Explains

October 19, 2023 — As shortages of basic drugs and treatments, for everything from lead poisoning to cancer, reach record levels in the US, the American Economic Liberties Project today released a new policy brief, “The Dirty Secret of Drug Shortages,” to shed light on the primary driver of the problem: consolidated middlemen known as group purchasing organizations (GPOs).